Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach.
作者信息
Alici Evren, Chrobok Michael, Lund Johan, Ahmadi Tahamtan, Khan Imran, Duru Adil D, Nahi Hareth
机构信息
Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Haematology Centre, Karolinska University Hospital Huddinge, Stockholm, Sweden.
出版信息
Br J Haematol. 2016 Aug;174(3):473-7. doi: 10.1111/bjh.13776. Epub 2015 Oct 12.
PMID:26455823
Abstract
摘要
Zotero 插件